Company intelligence / Profile preview

Astron Medtech

Ownership: Private
Development stage: Commercial

Overview

Astron Medtech has developed a minimally invasive surgical platform for soft tissue repair that enables precise suture placement with paratenon preservation. Clinical results show smaller incisions (~1 cm), faster recovery times, less pain, lower complication rates compared to traditional open surgery. Over 200 patients have been treated with positive outcomes including reduced scarring and improved function.

Therapeutic areas: OtherRheumatology
Modalities: Device (minimally invasive surgical system for tendon and ligament repair)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

TendMIN

Commercial

Indications: Achilles tendon rupture, Posterior bursitis, Soft tissue repair

Partnerships

Not explicitly listed; supported by partners in the orthopedic field and recognized by innovation programs such as MassChallenge, SelectUSA Medtech World Championship, UC Berkeley SPH Program

Beyond the preview

Go deeper on Astron Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astron Medtech.

Explore the full profile